Amplification of the antioxidant properties of myricetin, fisetin, and morin following their oxidation.

Antioxidants Benzofuranones Fisetin Flavonoid oxidation Functional food ingredients Morin Myricetin Quercetin

Journal

Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639

Informations de publication

Date de publication:
01 Mar 2024
Historique:
received: 09 06 2023
revised: 08 08 2023
accepted: 12 09 2023
medline: 26 10 2023
pubmed: 13 10 2023
entrez: 12 10 2023
Statut: ppublish

Résumé

Quercetin oxidation leads to the formation of a metabolite, 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-3(2H)-benzofuranone, whose antioxidant potency was recently reported to be a 1000-fold higher than that of its precursor. The formation of similar metabolites (BZF) is limited to certain flavonols (FL), among which are myricetin, fisetin, and morin. Here we addressed the consequences of inducing the auto-oxidation of these flavonols in terms of their antioxidant properties (assessed in ROS-exposed Caco-2 cells). The mixtures that result from their oxidation (FLox) exhibited antioxidant activities 10-to-50-fold higher than those of their precursors. Such amplification was fully attributable to the presence of BZF in each FLox (established by HPLC-ESI-MS/MS and chemical subtraction techniques). An identical amplification was also found when the antioxidant activities of BZF, isolated from each FLox, and FL were compared. These findings warrant the search of these BZF in edible plants and their subsequent evaluation as a new type of functional food ingredients.

Identifiants

pubmed: 37827059
pii: S0308-8146(23)02105-2
doi: 10.1016/j.foodchem.2023.137487
pii:
doi:

Substances chimiques

myricetin 76XC01FTOJ
Antioxidants 0
fisetin OO2ABO9578
morin 8NFQ3F76WR
Flavonoids 0
Flavonols 0
Quercetin 9IKM0I5T1E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137487

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

M Fernanda Arias-Santé (M)

Laboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, Santiago, Chile. Electronic address: mafernanda.arias@inta.uchile.cl.

Jocelyn Fuentes (J)

Laboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, Santiago, Chile. Electronic address: jfuentes@inta.uchile.cl.

Camila Ojeda (C)

Laboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, Santiago, Chile. Electronic address: cr.ojeda@uc.cl.

Mario Aranda (M)

Laboratory of Food & Drug Research, Department of Pharmacy, Faculty of Chemistry and Pharmacy, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: mario.aranda@uc.cl.

Edgar Pastene (E)

Laboratorio de Síntesis y Biotransformación de Productos Naturales, Departamento de Ciencias Básicas, Universidad del Bío-Bío, Chillán, Chile. Electronic address: epastene@ubiobio.cl.

Hernán Speisky (H)

Laboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, Santiago, Chile. Electronic address: hspeisky@inta.uchile.cl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH